466
Views
1
CrossRef citations to date
0
Altmetric
Review

Sedation in cardiac arrhythmias management

ORCID Icon, & ORCID Icon
Pages 163-173 | Received 09 Nov 2017, Accepted 16 Jan 2018, Published online: 21 Jan 2018

References

  • American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002;96:1004–1017.
  • Hernández-Madrid A, Svendsen JH, Lip GYH, et al. Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey. Europace. 2013;15:915–918.
  • Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962.
  • Mitchell-Hines T, Ellison K, Willis S. Using bispectral index monitoring to gauge depth of sedation/analgesia. Nurs Crit Care. 2017;12:12–16.
  • Kabukcu HK, Karakas MS, Yanikoglu A, et al. Use of bispectral index monitoring for determination of sedation depth in 50 patients undergoing cardioversion. J Pak Med Assoc. 2014;64:1370–1374.
  • Perel A. Non-anaesthesiologists should not be allowed to administer propofol for procedural sedation: a consensus statement of 21 European National Societies of Anaesthesia. Eur J Anaesthesiol. 2011;28:580–584.
  • Kaye P, Govier M. Procedural sedation with propofol for emergency DC cardioversion. Emerg Med J. 2014;31:904–908.
  • Wood J, Ferguson C. Procedural sedation for cardioversion. Emerg Med J. 2006;23:932–934.
  • Bawden J, Villa-Roel C, Singh M, et al. Procedural sedation and analgesia in a Canadian ED: a time-in-motion study. Am J Emerg Med. 2011;29:1083–1088.
  • Coll-Vinent B, Sala X, Bragulat E, et al. Sedation for cardioversion in the emergency department : analysis of effectiveness in four protocols. Ann Emerg Med. 2003;42:767–772.
  • Kundra T, Kaur P, Nagaraja P, et al. To evaluate dexmedetomidine as an additive to propofol for sedation for elective cardioversion in a cardiac intensive care unit: a double-blind randomized controlled trial. Ann Card Anaesth. 2017;20:337–340.
  • Parlak M, Parlak I, Erdur B, et al. Age effect on efficacy and side effects of two sedation and analgesia protocols on patients going through cardioversion: a randomized clinical trial. Acad Emerg Med. 2006;13:493–499.
  • Guerra F, Pavoni I, Romandini A, et al. Feasibility of a cardiologist-only approach to sedation for electrical cardioversion of atrial fibrillation: a randomized, open-blinded, prospective study. Int J Cardiol. 2014;176:930–935.
  • Guerra F, Stronati G, Mariotti G, et al. Safety and tolerability of a cardiologist-only approach to sedation for electrical cardioversion in the emergency department: the INSTEAD pilot trial. Int J Cardiol. 2016;223:766–767.
  • Mennuni M, Bianconi L, Antonicoli S, et al. Fast cardiologist-administered midazolam for electrical cardioversion of atrial fibrillation. J Cardiovasc Med (Hagerstown). 2007;8:176–180.
  • Notarstefano P, Pratola C, Toselli T, et al. Sedation with midazolam for electrical cardioversion. PACE Pacing Clin Electrophysiol. 2007;30:608–611.
  • Mitchell ARJ, Chalil S, Boodhoo L, et al. Diazepam or midazolam for external DC cardioversion (The DORM study). Europace. 2003;5:391–395.
  • Kezerashvili A, Fisher JD, DeLaney J, et al. Intravenous sedation for cardiac procedures can be administered safely and cost-effectively by non-anesthesia personnel. J Interv Card Electrophysiol. 2008;21:43–51.
  • Nevins MA. Ventricular arrhythmias and diazepam. JAMA. 1971;215:643.
  • de La Coussaye JE, Adnet F, Vivien B, et al. Sédation et analgésie en structure d’urgence. Quelles sont les modalités de sédation et/ou d’analgésie pour la réalisation d’un choc électrique externe? Ann Fr Anesth Reanim. 2012;31:343–346.
  • Tung RT, Bajai K. Safety of implantation of a cardioverter-defibrillator without general anesthesia in an electrophysiology. Am J Cardiol. 1995;75:908–912.
  • Pacifico A, Cedillo-Salazar FR, Nasir N, et al. Conscious sedation with combined hypnotic agents for implantation of implantable cardioverter-defibrillators. J Am Coll Cardiol. 1997;30:769–773.
  • Fox DJ, Davidson NC, Bennett DH, et al. Safety and acceptability of implantation of internal cardioverter-defibrillators under local anesthetic and conscious sedation. PACE Pacing Clin Electrophysiol. 2007;30:992–997.
  • Nichol G, Sayre MR, Guerra F, et al. Defibrillation for ventricular fibrillation. J Am Coll Cardiol. 2017;70:1496–1509.
  • Russo AM, Chung MK. Is defibrillation testing necessary for implantable transvenous defibrillators? Defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation. Circ Arrhythmia Electrophysiol. 2014;7:337–346.
  • Echt DS, Gremillion ST, Lee JT, et al. Effects of procainamide and lidocaine on defibrillation energy requirements in patients receiving implantable cardioverter defibrillator devices. J Cardiovasc Electrophysiol. 1994;5:752–760.
  • Nelson SD, Lenhart MB, Saffarin A. The influence of sodium channel blockade on the defibrillation energy requirements of biphasic versus monophasic shocks. Pacing Clin Electrophysiol. 1996;19:1568–1573.
  • Winecoff Miller AP, Sims JJ, McSwain R, et al. Lidocaine’s effect on defibrillation threshold are dependent on the defibrillation electrode system: epicardial versus endocardial. J Cardiovasc Electrophysiol. 1998;9:312–320.
  • Pharand C, Goldman R, Fan C, et al. Effect of chronic oral moricizine and intravenous epinephrine on ventricular fibrillation and defibrillation thresholds. Pacing Clin Electrophysiol. 1996;19:82–89.
  • Cohen TJ, Lowenkron DD. The effects of pneumothorax on defibrillation thresholds during pectoral implantation of an active can implantable cardioverter defibrillator. PACE Pacing Clin Electrophysiol. 1998;21:468–470.
  • Knight BP, Pelosi F, Flemming M, et al. Effect of general anesthesia on the defibrillation energy requirement in patients undergoing defibrillator implantation. J Interv Card Electrophysiol. 1999;3:325–328.
  • Camci E, Koltka K, Sungur Z, et al. Implantable cardioverter-defibrillator placement in patients with mild-to-moderate left ventricular dysfunction: hemodynamics and recovery profile with two different anesthetics used during deep sedation. J Cardiothorac Vasc Anesth. 2003;17:613–616.
  • Marquié C, Duchemin A, Klug D, et al. Can we implant cardioverter defibrillator under minimal sedation? Europace. 2007;9:545–550.
  • Sayfo S, Vakil KP, Alqaqa’AA, et al. A retrospective analysis of proceduralist-directed, nurse-administered propofol sedation for implantable cardioverter-defibrillator procedures. Hear Rhythm. 2012;9:342–346.
  • Healey JS, Brambatti M. Is defibrillation testing necessary for implantable transvenous defibrillators? Defibrillation testing should not be routinely performed at the time of implantable cardioverter defibrillator implantation. Circ Arrhythmia Electrophysiol. 2014;7:347–351.
  • Pfau G, Schilling T, Kozian A, et al. Outcome after implantation of cardiac resynchronization/defibrillation systems in patients with congestive heart failure and left bundle-branch block. J Cardiothorac Vasc Anesth. 2010;24:30–36.
  • Theron P, Guha K, Mantziari L, et al. General anesthesia versus sedation for implantation of a biventricular pacing device for cardiac resynchronization therapy. J Cardiothorac Vasc Anesth. 2014;28:280–284.
  • Looi K-L, Lee ASY, Cole K, et al. Conscious sedation and analgesia use in cardiac device implantation. Int J Cardiol. 2013;168:561–563.
  • Bardy GH, Smith WM, Hood MA, et al. An entirely subcutaneous implantable cardioverter–defibrillator. N Engl J Med. 2010;363:36–44.
  • Burke MC, Gold MR, Knight BP, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator. J Am Coll Cardiol. 2015;65:1605–1615.
  • Essandoh MK, Portillo JG, Weiss R, et al. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience. J Clin Anesth. 2016;31:53–59.
  • Kuck K-H, Brugada J, Fürnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235–2245.
  • Di Biase L, Conti S, Mohanty P, et al. General anesthesia reduces the prevalence of pulmonary vein reconnection during repeat ablation when compared with conscious sedation: results from a randomized study. Hear Rhythm. 2011;8:368–372.
  • Di Biase L, Saenz LC, Burkhardt DJ, et al. Esophageal capsule endoscopy after radiofrequency catheter ablation for atrial fibrillation: documented higher risk of luminal esophageal damage with general anesthesia as compared with conscious sedation. Circ Arrhythmia Electrophysiol. 2009;2:108–112.
  • Firme EBP, Cavalcanti IL, Barrucand L, et al. Curative ablation of atrial fibrillation: comparison between deep sedation and general anesthesia. Rev Col Bras Cir. 2012;39:462–468.
  • Gerstein NS, Young A, Schulman PM, et al. Sedation in the electrophysiology laboratory: a multidisciplinary review. J Am Heart Assoc. 2016;5:1–13.
  • Mountantonakis SE, Elkassabany N, Kondapalli L, et al. Provocation of atrial fibrillation triggers during ablation: does the use of general anesthesia affect inducibility? J. Cardiovasc Electrophysiol. 2015;26:16–20.
  • Takigawa M, Takahashi A, Kuwahara T, et al. Airway support using a pediatric intubation tube in adult patients with atrial fibrillation: a simple and unique method to prevent heart movement during catheter ablation under continuous deep sedation. J Arrhythmia. 2017;33:262–268.
  • Hida S, Takemoto M, Masumoto A, et al. Clinical benefits of deep sedation with a supraglottic airway while monitoring the bispectral index during catheter ablation of atrial fibrillation. J Arrhythmia. 2017;33:283–288.
  • Murakami T, Yamaji H, Numa K, et al. Adaptive-servo ventilation combined with deep sedation is an effective strategy during pulmonary vein isolation. Europace. 2013;15:951–956.
  • Tang R, Dong J, Zhao W, et al. Unconscious sedation/analgesia with propofol versus conscious sedation with fentanyl/midazolam for catheter ablation of atrial fibrillation: a prospective, randomized study. Chin Med J (Engl). 2007;120:2036–2038.
  • Kottkamp H, Hindricks G, Eitel C, et al. Deep sedation for catheter ablation of atrial fibrillation: a prospective study in 650 consecutive patients. J Cardiovasc Electrophysiol. 2011;22:1339–1343.
  • Salukhe TV, Willems S, Drewitz I, et al. Propofol sedation administered by cardiologists without assisted ventilation for long cardiac interventions: an assessment of 1000 consecutive patients undergoing atrial fibrillation ablation. Europace. 2012;14:325–330.
  • Wutzler A, Loehr L, Huemer M, et al. Deep sedation during catheter ablation for atrial fibrillation in elderly patients. J Interv Card Electrophysiol. 2013;38:115–121.
  • Wasserlauf J, Knight BP, Li Z, et al. Moderate sedation reduces lab time compared to general anesthesia during cryoballoon ablation for AF without compromising safety or long-term efficacy. PACE Pacing Clin Electrophysiol. 2016;39:1359–1365.
  • Cho JS, Shim JK, Na S, et al. Improved sedation with dexmedetomidine-remifentanil compared with midazolam-remifentanil during catheter ablation of atrial fibrillation: a randomized, controlled trial. Europace. 2014;16:1000–1006.
  • Sairaku A, Yoshida Y, Hirayama H, et al. Procedural sedation with dexmedetomidine during ablation of atrial fibrillation: a randomized controlled trial. Europace. 2014;16:994–999.
  • Attanasio P, Huemer M, Shokor Parwani A, et al. Pain reactions during pulmonary vein isolation under deep sedation: cryothermal versus radiofrequency ablation. PACE Pacing Clin Electrophysiol. 2016;39:452–457.
  • Lai LP, Lin JL, Wu MH, et al. Usefulness of intravenous propofol anesthesia for radiofrequency catheter ablation in patients with tachyarrhythmias: infeasibility for pediatric patients with ectopic atrial tachycardia. PACE Pacing Clin Electrophysiol. 1999;22:1358–1364.
  • Kovoor P, Porter R, Uther JB, et al. Efficacy and safety of a new protocol for continuous infusion of midazolam and fentanyl and its effects on patient distress during electrophysiological studies. PACE Pacing Clin Electrophysiol. 1997;20:2765–2774.
  • Wutzler A, Huemer M, Boldt LH, et al. Effects of deep sedation on cardiac electrophysiology in patients undergoing radiofrequency ablation of supraventricular tachycardia: impact of propofol and ketamine. Europace. 2013;15:1019–1024.
  • Liu Q, Kong A, Chen R, et al. Propofol and arrhythmias: two sides of the coin. Acta Pharmacol Sin. 2011;32:817–823.
  • Wutzler A, Mueller A, Loehr L, et al. Minimal and deep sedation during ablation of ventricular tachycardia. Int J Cardiol. 2014;172:161–164.
  • Nof E, Reichlin T, Enriquez AD, et al. Impact of general anesthesia on initiation and stability of VT during catheter ablation. Hear Rhythm. 2015;12:2213–2220.
  • Servatius H, Höfeler T, Hoffmann BA, et al. Propofol sedation administered by cardiologists for patients undergoing catheter ablation for ventricular tachycardia. Europace. 2016;18:1245–1251.
  • Miró O, de la Red G, Fontanals J. Cessation of paroxysmal atrial fibrillation during acute intravenous propofol administration. Anesthesiology. 2000;92:910.
  • Kannan S, Sherwood N. Termination of supraventricular tachycardia by propofol. Br J Anaesth. 2002;88:874–875.
  • Burjorjee JE, Milne B. Propofol for electrical storm; a case report of cardioversion and suppression of ventricular tachycardia by propofol. Can J Anesth Can d’anesthésie. 2002;49:973–977.
  • Mulpuru SK, Patel DV, Wilbur SL, et al. Electrical storm and termination with propofol therapy: a case report. Int J Cardiol. 2008;128:6–8.
  • Guerra F, Flori M, Bonelli P, et al. Electrical storm and heart failure worsening in implantable cardiac defibrillator patients. Europace. 2014;17:247–254.
  • Morey TE, Martynyuk AE, Napolitano CA, et al. Ionic basis of the differential effects of intravenous anesthetics on erythromycin-induced prolongation of ventricular repolarization in the guinea pig heart. Anesthesiology. 1997;87:1172–1181.
  • Hirata N, Kanaya N, Kamada N, et al. Differential effects of propofol and sevoflurane on ischemia-induced ventricular arrhythmias and phosphorylated connexin 43 protein in rats. Anesthesiology. 2009;110:50–57.
  • Booker PD, Whyte SD, Ladusans EJ. Long QT syndrome and anaesthesia. Br J Anaesth. 2003;90:349–366.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.